Jan 13, 2019 | Financial Planning
Earlier this week, Bluebird Bio announced it may have a found a way to handle the expected seven-figure cost of its experimental gene therapy: getting customers to pay on installment. The price of its therapy to rare inherited blood disease is expected to be ~$2...
Dec 21, 2018 | Financial Planning
At Future Wealth, our philosophy is simple: We believe most investors stay away from investing in Wall Street for two reasons – First, they don’t have enough money and second, they don’t want to lose money. While we at Future Wealth can’t help with the first, our...
Dec 2, 2018 | Financial Planning
Earlier this week, Payless Shoesource, a company that is just emerging from bankruptcy, with nothing to lose, pulled off a reverse of a bait-and-switch operation in an event held in Santa Monica, California. Payless took over a former Armani store, renamed the retail...
Sep 3, 2018 | Financial Planning
Earlier this week, Merrill Lynch announced that it is nixing a ban on charging commissions in retirement accounts, marking a reversal for the Wall street brokerage that just a few years ago said fee-based services are better for clients. It is now clear that the...
Jul 8, 2018 | Financial Planning
Social Security has been a financial foundation that millions of retirees simply couldn’t do without. More than three out of every five retirees count on the program for at least half of their monthly income. But this guaranteed payout is in some serious trouble...
Apr 22, 2018 | Financial Planning
In an article earlier this week in the Wall Street Journal, it was revealed that hundreds of colleges and universities are using scholarships and merit based financial aid as tool to attract students to their programs. At Tulane University in New Orleans, 39% of...
